BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 22728756)

  • 1. Efficacy and safety of oral oseltamivir for influenza prophylaxis in transplant recipients.
    Ison MG; Szakaly P; Shapira MY; Kriván G; Nist A; Dutkowski R
    Antivir Ther; 2012; 17(6):955-64. PubMed ID: 22728756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of inhaled zanamivir in the prevention of influenza in community-dwelling, high-risk adult and adolescent subjects: a 28-day, multicenter, randomized, double-blind, placebo-controlled trial.
    LaForce C; Man CY; Henderson FW; McElhaney JE; Hampel FC; Bettis R; Kudule L; Harris J; Yates P; Tisdale M; Webster A
    Clin Ther; 2007 Aug; 29(8):1579-90; discussion 1577-8. PubMed ID: 17919541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China.
    Cao B; Li XW; Mao Y; Wang J; Lu HZ; Chen YS; Liang ZA; Liang L; Zhang SJ; Zhang B; Gu L; Lu LH; Wang DY; Wang C;
    N Engl J Med; 2009 Dec; 361(26):2507-17. PubMed ID: 20007555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of oseltamivir treatment started within 5 days of symptom onset to reduce influenza illness duration and virus shedding in an urban setting in Bangladesh: a randomised placebo-controlled trial.
    Fry AM; Goswami D; Nahar K; Sharmin AT; Rahman M; Gubareva L; Azim T; Bresee J; Luby SP; Brooks WA
    Lancet Infect Dis; 2014 Feb; 14(2):109-18. PubMed ID: 24268590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral drugs in influenza: an adjunct to vaccination in some situations.
    Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oseltamivir compared with the Chinese traditional therapy maxingshigan-yinqiaosan in the treatment of H1N1 influenza: a randomized trial.
    Wang C; Cao B; Liu QQ; Zou ZQ; Liang ZA; Gu L; Dong JP; Liang LR; Li XW; Hu K; He XS; Sun YH; An Y; Yang T; Cao ZX; Guo YM; Wen XM; Wang YG; Liu YL; Jiang LD
    Ann Intern Med; 2011 Aug; 155(4):217-25. PubMed ID: 21844547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influenza A/H1N1 2009 pneumonia in kidney transplant recipients: characteristics and outcomes following high-dose oseltamivir exposure.
    Watcharananan SP; Suwatanapongched T; Wacharawanichkul P; Chantratitaya W; Mavichak V; Mossad SB
    Transpl Infect Dis; 2010 Apr; 12(2):127-31. PubMed ID: 20102550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oseltamivir: new indication. Prevention of influenza in at-risk children: vaccination is best.
    Prescrire Int; 2007 Feb; 16(87):9-11. PubMed ID: 17323516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and tolerability of oseltamivir prophylaxis in hematopoietic stem cell transplant recipients: a retrospective case-control study.
    Vu D; Peck AJ; Nichols WG; Varley C; Englund JA; Corey L; Boeckh M
    Clin Infect Dis; 2007 Jul; 45(2):187-93. PubMed ID: 17578777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza.
    Hayden FG; Atmar RL; Schilling M; Johnson C; Poretz D; Paar D; Huson L; Ward P; Mills RG
    N Engl J Med; 1999 Oct; 341(18):1336-43. PubMed ID: 10536125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-exposure prophylaxis for H1N1 with oseltamivir in renal allograft recipient--safe and effective without any immunosuppresive drug interaction.
    Kute V; Goplani KR; Godara SM; Shah PR; Vanikar AV; Trivedii HL
    J Assoc Physicians India; 2011 Jan; 59():49-51. PubMed ID: 21751666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural herbal medicine Lianhuaqingwen capsule anti-influenza A (H1N1) trial: a randomized, double blind, positive controlled clinical trial.
    Duan ZP; Jia ZH; Zhang J; Liu S; Chen Y; Liang LC; Zhang CQ; Zhang Z; Sun Y; Zhang SQ; Wang YY; Wu YL
    Chin Med J (Engl); 2011 Sep; 124(18):2925-33. PubMed ID: 22040504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multicenter evaluation of pandemic influenza A/H1N1 in hematopoietic stem cell transplant recipients.
    Reid G; Huprikar S; Patel G; Razonable RR; Mossad S; Levi M; Gregg K; Shoham S; Humar A; Adams W; Kumar D
    Transpl Infect Dis; 2013 Oct; 15(5):487-92. PubMed ID: 23890293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oseltamivir ring prophylaxis for containment of 2009 H1N1 influenza outbreaks.
    Lee VJ; Yap J; Cook AR; Chen MI; Tay JK; Tan BH; Loh JP; Chew SW; Koh WH; Lin R; Cui L; Lee CW; Sung WK; Wong CW; Hibberd ML; Kang WL; Seet B; Tambyah PA
    N Engl J Med; 2010 Jun; 362(23):2166-74. PubMed ID: 20558367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. H1N1 infection in a cohort of hematopoietic stem cell transplant recipients: prompt antiviral therapy might be life saving.
    Suyani E; Aki Z; Güzel Ö; Altindal S; Senol E; Sucak G
    Transpl Infect Dis; 2011 Apr; 13(2):208-12. PubMed ID: 21214698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and pharmacokinetics of oseltamivir for prophylaxis of neonates exposed to influenza H1N1.
    Maltezou HC; Drakoulis N; Siahanidou T; Karalis V; Zervaki E; Dotsikas Y; Loukas YL; Theodoridou M
    Pediatr Infect Dis J; 2012 May; 31(5):527-9. PubMed ID: 22209917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of H274Y oseltamivir-resistant A(H1N1) influenza viruses in Japan during the 2008-2009 season.
    Baranovich T; Saito R; Suzuki Y; Zaraket H; Dapat C; Caperig-Dapat I; Oguma T; Shabana II; Saito T; Suzuki H;
    J Clin Virol; 2010 Jan; 47(1):23-8. PubMed ID: 19962344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transplantation of solid organs procured from influenza A H1N1 infected donors.
    Cockbain AJ; Jacob M; Ecuyer C; Hostert L; Ahmad N
    Transpl Int; 2011 Dec; 24(12):e107-10. PubMed ID: 21954984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and safety of intravenous oseltamivir in infants and children in open-label studies.
    Muñoz FM; Anderson EJ; Deville JG; Clinch B; Kamal MA
    Int J Clin Pharmacol Ther; 2015 Jul; 53(7):531-40. PubMed ID: 26042486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of influenza infections in outpatients after allogeneic hematopoietic stem cell transplantation.
    Khanna N; Steffen I; Studt JD; Schreiber A; Lehmann T; Weisser M; Flückiger U; Gratwohl A; Halter J; Hirsch HH
    Transpl Infect Dis; 2009 Apr; 11(2):100-5. PubMed ID: 19175540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.